유의사항 본자료의재무정보는한국채택국제회계기준에따라작성된연결기준의영업실적입니다. 본자료는미래에대한 예측정보 를포함하고있습니다. 이는과거가아닌미래의사건과관계된것으로회사의향후예상되는경영현황및재무실적을의미하고, 표현상으로는 예상, 전망, 계획, 기대 등과같은단어를포함합니다. 예측정보 는그성격상불확실한사건들을언급하는데, 회사의향후경영현황및재무실적에긍정적또는부정적으로영향을미칠수있는불확실성에는다음과같은것들이포함됩니다. 환율, 이자율등의변동을포함한국내 외금융시장의동향 사업의처분, 인수등을포함한회사의전략적인의사결정 회사가영위하는주요사업분야의예상치못한급격한여건변화 기타경영현황및재무실적에영향을미칠수있는국내 외적변화 이러한불확실성으로인해회사의실제미래실적은 예측정보 에명시적또는묵시적으로포함된내용과중대한차이가있을수있음을 양지하시기바랍니다. 1
I. Company Overview II. III. IV. Business & Products Investment Highlight Appendix
2018 Investor Relations Company Overview 3
I-1 Company Profile World s Best Biometric Company with Innovative Technologies Company Overview 사명 슈프리마 지배구조 설립일 2015.12.31 ( 인적분할전설립일 2004.05.04) 주요경영진문영수, 송봉섭대표이사 ( 각자대표 ) SUPREMA HQ [ 지주회사 ] 종업원수 148 명 (2018. 09 기준 ) R&D 투자매출액의 15% (2018. 09 기준 ) SUPREMA SUPREMA ID [ID solution] 기타 주소경기도성남시분당구정자일로 248 기타 54.3% 35.7% 외국인 SUPREMA Shareholders 최대주주및특수관계인 SUPREMA HQ 25.9% 특수관계인 9.8% 5.1% 6.2% [as of Nov 2018] 4
I-2 Stable Growth & Financial Structure Solid Growth with High Margin and Heathy Financial Structure Company Overview 분기별매출및이익율 자산 vs 부채 ( 단위 : 십억원, %) ( 단위 : 십억원, %) 53.4% 53.0% 51.8% 54.1% 55.4% 53.0% 53.1% 26.8% 20.2% 24.0% 32.4% 22.2% 21.3% 19.8% 6% 8% 7% 6% 6% 5% 5% 1Q 2Q 3Q 4Q 1Q 2Q 3Q 2017 2018 Revenue GPM OPM 1Q 2Q 3Q 4Q 1Q 2Q 3Q 2017 2018 Asset Liabilities Debt Ratio 2017 2018 ( 단위 : 십억원,%) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 매출액 9.5 11.2 11.1 15.2 11.2 13.4 12.9 매출총이익 5.1 6 5.8 8.2 5 7.1 6.9 영업이익 2.5 2.3 2.7 4.9 2.5 2.9 2.7 순이익 0.4 3.5 3.4 1.8 1.7 5.7 2.6 2017 2018 ( 단위 : 십억원,%) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 자산총액 94.2 99.6 102.6 103.3 104.7 110.3 112.9 부채총액 5.6 7.6 7.1 6.1 5.8 5.5 5.5 부채비율 6% 8% 7% 6% 6% 5% 5% 5
I-3 Sales Breakdown Solid Growth with High Margin and Heathy Financial Structure Company Overview 제품별매출비중 지역별매출비중 9% 14% 5% 21% 9% 27% 2017 년매출 47,062 백만원 70% 13% 2017 년매출 47,062 백만원 11% 21% BioStar SFM+BioSign Others Africa Asia Europe L.America M.East N.America Korea 6
2018 Investor Relations Business & Products 7
II Business Area & Products Overview Product diversification for Leading the Industries Business & Products BioSign BioStar SFM 스마트폰용지문인식솔루션 출입보안및근태관리시스템 ( 지문 & 얼굴인식 ) 지문인식코어테크놀로지 ( 지문인식모듈 ) Under-Display 알고리즘엔터프라이즈급출입보안솔루션국내근태시장 ( 주 52 시간제 ) 사업확대 13.5mm 초박형지문인식센서모듈 (Slim Module) 8
II-1 BioSign Key Features World s Best Performing Fingerprint Authentication Algorithm for Smartphone Business & Products BioSign 2.0 (Capacity Sensor) Flexibility in Design Fastest Speed Most Accurate Robust Performance over Time World s Smallest Sensor [4x4, 4x3mm) Supporting Any Sensor Types & Forms 50ms Authentication Time 50% Lower FRR than Major Player Technology gets smarter with use BioSign 3.0 (Under-display Sensor) [ 출처 : KTB 증권 Report 핸드셋앞서보는신기술 FOD 2018.05] 9
II-1 BioSign Market & Strategies Increasing Fingerprint Penetration & BioSignMarket Share Business & Products 80% 스마트폰지문인식침투율 71% (Million Unit) 350 디스플레이지문인식센서출하량및성장율 107% 120% 70% 60% 50% 40% 30% 20% 10% 3% 14% 25% 45% 58% 300 250 200 150 100 50 96% 35% 18% 100% 80% 60% 40% 20% 0% 2013 2014 2015 2016 2017 2018 (Source : Counterpoint Technology Market Research) 0 0% 2018 2019 2020 2021 2022 Unit Growth (Source : 2018 IHS Report) BioSign 전략 프리미엄스마트폰용차세대지문인식기술 Under-Display 시장진입및선점 중저가스마트폰용초소형센서시장점유율제고 글로벌주요센서업체와협력관계강화 (Under-Display & 정전방식센서 ) 세트메이커기준고객다변화 ( 한국 중국등 ) 10
II-1 BioSign Fingerprint Integration Roadmap Seamless Technology Development Business & Products 11
II-1 BioSign Market Eco System SUPREMA s Co-working in Smartphone supply chain Business & Products Packaging Sensor Fingerprint Algorithm Device 12
Controller Readers II-2 BioStar Key Features Biometric Systems for Access Control & Time Attendance Mangement Business & Products 1 st Gen Products 2 nd Gen Products BioStation Series FaceStation BioStation2 FaceStation2 N2 (Q1 18) Xpass D2 [M] (Q1 18) Xpass D2 [G] (Q1 18) A2 W2 L2 P2 R2 S/W BioStar 1 BioStar 2 CoreStation (Q3, 17) BioStation [Fingerprint Reader] FaceStation [Face Recognition Reader] CoreStation [Controller] World s Fastest Performance World s Fastest Performance Intelligent Centralized Biometric Access Control The Most Accurate & Highest Security - Advanced Live Finger Detection Highest Operating Illuminance - 0 lux to 25,000lux Enterprise-level Capacity - Max 500,000 user Improved Security Best in Class Features Enhanced Security - Live Face Detection - IR based Technology System Flexibility & Scalability 13
II-2 BioStar AC & TA Market SUPREMA is well acknowledged as a best player in industry leading technologies Business & Products 출입보안시장규모 근태관리시장규모 4.0 [UNIT : U$ Billion] 6.0 [UNIT : U$ Billion] 3.0 5.0 4.0 2.0 3.0 1.0 2.0 1.0 0.0 2016 2017 2018 2019 0.0 2016 2017 2018 2019 Americas EMEA Asia [Source : IHS Report 2016] Americas EMEA Asia [Source : IHS Report 2015] 출입통제시장구성 근태관리시장구성 Card 17% Controller 47% S/W 12% U$2.6Billion [as of 2016] Reader 29% U$ 0.8 Billion Biometric 32% RFID 60% [Source : IHS Report 2016] Other1% Multi-Tech 7% Service 31% SaaS 21% Installation 14% U$4.7 Billion [as of 2016] S/W 18% H/W 16% U$ 0.7 Billion Time Card 6% Smart Card 16% Proximity Card 20% Pin Entry 2% Magnetic 5% Barcode 12% Biometric 39% [Source : IHS Report 2017] 14
II-2 BioStar Plan to Expansion Expanding the Product Portfolio to Controller, Biggest Market of AC Market Business & Products 출입보안시장의메인시장인컨트롤러로제품다변화및엔터프라이즈급시장진입 CoreStation Reader 29% 지능형바이오인식중앙제어시스템 출입통제시장구성 U$2.6Billion [as of 2016] Controller 47% 컨트롤러시장진입 Card 17% S/W 12% [Source : IHS Report 2016] 1
II-2 BioStar Plan to Expansion Customer Diversification into Domestic Market Business & Products 주 52 시간근무제시행 으로정확한근태관리를위한국내근태시장의바이오인식제품도입전망 유연근무 선택근무 탄력근무 국내근태관리시장의 바이오인식제품적용 및수요증대 휴게시간, 점심시간, 이동시간등업무와관련없는시간제외 Why SUPREMA? 글로벌근태관리시장진출 국내근태관리시장진출 검증된근태관리솔루션 세계최고제품및서비스 전세계 100 여개국의다양한근로기준법에맞는제품공급실적다수보유 현대건설등국내대형건설사의국내외건설현장노무자관리시스템공급등 세계최고수준의바이오인식기술적용을통한제품의신뢰성 국내최장 3 년무상서비스적용 16
II-2 BioStar Plan to Expansion Customer Diversification into Domestic Market Business & Products SK 계열사 NSOK 무인경비 (OEM 사업 ) SKT T-View 스마트출입통제 ( 정규 Brand) Cloud 서버를통한스마트보안시스템 (Without Local PC or S/W) 17
II-2 BioStar Achievement & Plan to Expansion Expanding the Product Portfolio to Controller, Biggest Market of AC Market Business & Products 슈프리마시장점유율 ( 글로벌출입통제시장 ) Top 1 EMEA Top 2 World-wide Top 4 America Top 3 APAC BioStar 전략 2세대신제품라인업및매출확대 주52시간제시행에따라국내근태시장선점 국내사업다각화 (SK OEM사업, SKT 스마트출입보안시스템등 ) 제품포트폴리오확대 ( 바이오인식 컨트롤러 ) 및신제품컨터롤러시장진입 현지화전략을통한전략지역 ( 유럽, 북미, 중동 ) 시장점유율제고 18
New Product SFM Series II-3 SFM Key features World s Most Widely-Used Embedded Fingerprint Module Business & Products 2004 2009 2010 2017 2018 SFM 3000 SFM 4000 SFM 5000 SFM 6000 SFM Slim Fastest Speed World s Fastest Matching Speed up to 5,000 match/sec Most Accurate EER less than 0.08% Industry Leading Live Finger Detection FBI Certification SFM Over 1,000,0000 SFM Fingerprint Modules Sold Worldwide Over 100 countries Technology reached 19
II-3 SFM Recent Innovation SFM Slim, The World s Slimmest Embedded fingerprint module Business & Products SFM Slim High Precision FAP20 Compliant Embedded Fingerprint Module FAP20 certification SFM Slim vs CBM (OT-Morpho) FAP10 certification 13.5mm vs 13.6mm 13.5mm, The World s Slimmest FAP20 Optical Fingerprint Sensor THE WORLD S SLIMMEST FAP20 OPTICAL FINGERPRINT SENSOR CBM-E3 MDR (Multi Dynamic Range) Technology 고성능위조지문방지 LFD (Live Finger Detection) 최고의인증속도 1:1000 / 0.4 sec Mass templates storage Up to 22,000 Supporting serial and USB interfaces Easy integration without additional bracket 20
II-3 SFM Market & Strategies World s Most Widely-Used Embedded Fingerprint Module Business & Products Global No.1 Module - SFM Module Demand by Module Type Global EU NA 23% 77% 38% 62% ME 90% 10% 62% Asia 38% 47% 53% SA 60% 40% 17% Africa 83% Oceania 4% 96% Slim type module Legacy type module SFM 전략 프리미엄제품및디자인선호도가높은선진북미및유럽의 Slim Module시장진입 핵심기술력강화및기술주도력제고 -고성능지문인식기술 -매칭속도및정확도 ( 최저 FRR/FAR ) 제고 IoT 및자동차분야등다양한분야로확대가능한모듈및기술개발 21
II-4 Business Outlook Sustainable Growth and Profit based on Leading Product Line-up Business & Products 기술및시장의변화에선제적대응하고, 신제품조기출시를통해지속성장 분기별매출및이익현황 52.9% 53.3% 51.1% 54.3% 54.4% 53.0% 53.1% 33.3% 26.7% 20.8% 23.8% 22.1% 21.3% 19.80% 2017 Q1 2017 2Q 2017 3Q 2017 4Q 2018 1Q 2018 2Q 2018 3Q 2018 4Q(F) 매출액매출총이익영업이익매출총이익율영업이익율 22
2018 Investor Relations Investment Highlights 23
III-1 2 nd Take-off as Product Diversification Product & Market Diversification drives the Sustainable growth Investment Highlights 2G 신제품, 전략지역및국내매출확대로지속적인성장기틀구축 BioSign 프리미엄스마트폰용차세대센서 Under-Display 시장진입및선점 중저가스마트폰용초소형센서시장점유율제고 글로벌주요센서업체와협력관계강화 BioStar SFM 주52시간제시행에따라국내근태시장선점 2G 신제품매출확대 (FST 2 등 ) 현지화전략을통한전략지역 ( 북미, 유럽, 중동 ) 시장점유율확대 엔터프라이즈급출입보안시장진입 (CoreStation) 프리미엄제품및디자인선호도가높은북미및유럽 Slim 모듈시장진입 IoT 및자동차등다양한분야에적용가능한모듈개발 24
III-2 Global Sales Reach & Network Customer diversification across appx 1000 partners over 100 countries Investment Highlights Customer Diversification across 1000 partners over 100 countries 21% 24% 27% 24% 11% 9% 18% 13% 11% 16% 5% 7% Overseas Sales in 2017 86% 25
III-3 Global Partners Customer diversification across appx 1000 partners over 100 countries Investment Highlights 26
III-4 Global Brand Awareness Various product portfolio based global brand power Investment Highlights 27
III-5 In-house R&D Capability The Capabilities for World s Best Biometric Technologies 연구개발인력 전체임직원의 80% 우수한석 / 박사급연구인력 전체임직원의 23% Investment Highlights The year of Biometric Company R&D Admin/ Others Sales 12% 80% Chairman JW Lee Ph D/Seoul Nat l Univ. CEO BS Song Ph D/Seoul Nat l Univ. V.President YS Moon Ph D/Seoul Nat s Univ. V.President HS Yang PhD/Seoul Nat s Univ. Director BG Park Ph D/Seoul Nat s Univ. Director SY Lee PhD/Seoul Nat s Univ. Director KJ Seo Ph D/KAIST Director HC Kim Master / Univ of Wisconsin Director SJ Lee Master /Seoul Nat s Univ. Director DM Shin Master / Korea Univ. 연구개발비 매출액의 15~17% 지적재산권 국내외등록특허 83 건국내외출원특허 44 건 16% 17% 17% [As of Sept 2017] 15% 2014 2015 2016 2017 28
2018 Investor Relations Appendix 29
Face Recognition Technology (SUPREMA vs iphone X) Business & Products Similar but BIG Different Infrared Camera Flood Illuminator Dot Projector IR Camera IR Illumination 3D Sensing SUPREMA S FaceStation 2 iphone X Operating Mode Security (FAR) Accuracy (FRR) Matching Speed Operating Illumination Features FaceStation 2 [SUPREMA] Identification 1:3000 1/5,000,000 < 1% < 0.5ms Up to 25,000 LUX 특허받은위조인증방지를위한 LFD 기능 User 연령제한없음 iphone X [APPLE] Verification 1:1 1/1,000,000 N/A 1~2 seconds N/A Machine Learning 13 세이하어린이사용자제권고 30
재무상태표 ( 연결 ) Investment Highlights ( 단위 : 백만원 ) 2015년 2016 2017 2018 4분기 1분기 2분기 3분기 4분기 1분기 2분기 3분기 4분기 1분기 2분기 3분기 유동자산 46,716 48,273 51,524 52,284 58,464 57,339 63,141 65,854 65,044 65,909 71,049 73,806 현금및현금성자산 12,838 12,544 15,558 19,841 31,925 33,226 23,467 27,276 31,256 31,953 26,438 17,399 유동금융자산 21,923 24,025 21,826 18,499 14,238 13,673 26,335 24,674 17,530 19,715 26,327 39,174 매출채권등 4,653 5,371 6,569 5,516 7,789 5,408 6,437 6,872 8,084 5,337 7,981 7,392 재고자산 6,048 5,119 5,959 6,747 5,300 5,032 6,115 6,888 6,490 8,836 8,798 8,391 비유동자산 34,384 35,787 35,779 36,039 36,204 36,894 36,473 36,770 38,235 38,755 39,227 39,124 비유동금융자산 19,531 20,949 21,045 21,007 21,040 21,849 20,744 18,204 21,733 23,191 23,882 27,274 유형자산 6,495 6,363 6,248 6,078 5,202 5,095 4,978 4,978 4,968 5,027 5,423 5,408 무형자산 8,206 8,255 8,231 8,652 8,885 9,195 9,350 9,393 9,479 9,410 9,137 8,738 자산총계 81,100 84,060 87,303 88,323 94,667 94,233 99,614 102,624 103,279 104,664 110,277 112,930 유동부채 3,616 3,874 4,126 3,733 5,806 4,959 6,907 6,312 5,302 5,057 4,729 4,709 차입금 0 0 0 매입채무 2,551 2,661 2,902 3,339 4,710 4,214 6,217 5,411 3,987 4,103 3,664 3,500 비유동부채 354 444 507 601 630 669 713 761 761 791 761 751 부채총계 3,970 4,318 4,633 4,334 6,435 5,629 7,620 7,073 6,064 5,848 5,490 5,461 자본금 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 자본잉여금 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 자본총계 77,130 79,742 82,670 83,989 88,232 88,604 91,994 95,551 97,215 98,816 104,786 107,469 31
재무상태표 ( 개별 ) Investment Highlights ( 단위 : 백만원 ) 2015년 2016 2017 2018 4분기 1분기 2분기 3분기 4분기 1분기 2분기 3분기 4분기 1분기 2분기 3분기 유동자산 46,716 48,273 51,524 52,146 58,392 57,238 63,128 65,744 64,968 65,755 70,917 73,492 현금및현금성자산 12,838 12,544 15,558 19,729 31,857 33,191 23,414 27,147 31,140 31,855 26,262 17,209 유동금융자산 21,923 24,025 21,826 18,499 13,284 12,856 26,335 24,670 17,530 19,725 26,426 39,123 매출채권등 4,653 5,371 6,569 5,554 7,856 5,401 6,572 7,023 8,184 5,449 8,135 7,524 재고자산 6,048 5,119 5,959 6,686 5,233 4,976 6,024 6,762 6,401 8,657 8,646 8,250 비유동자산 34,384 35,787 35,779 36,142 36,354 37,038 36,615 36,939 38,438 38,958 39,429 39,322 비유동금융자산 19,531 20,949 21,045 21,007 21,503 20,838 21,204 18,204 21,730 23,188 23,882 18,536 유형자산 6,495 6,363 6,248 6,077 5,198 5,090 4,973 4,951 4,962 5,020 5,413 5,395 무형자산 8,206 8,255 8,231 8,296 8,577 8,887 9,041 9,085 9,171 9,102 8,829 8,430 자산총계 81,100 84,060 87,303 88,288 94,746 94,276 99,743 102,684 103,406 104,714 110,345 112,814 유동부채 3,616 3,874 4,126 3,720 5,797 4,948 6,918 6,290 5,256 4,971 4,620 4,561 차입금 0 0 0 0 0 0 0 0 매입채무 2,551 2,661 2,902 3,327 4,701 4,203 6,227 5,390 3,941 4,018 3,562 3,364 비유동부채 354 444 507 601 630 669 713 761 761 791 761 751 부채총계 3,970 4,318 4,633 4,321 6,427 5,618 7,631 7,052 6,018 5,763 5,382 5,313 자본금 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 3,540 기타불입자본금 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 73,244 자본총계 77,130 79,742 82,670 83,967 88,319 88,658 92,112 95,632 97,388 98,951 104,964 107,501 32
손익계산서 ( 연결 ) Investment Highlights 2017년 2018년 ( 단위 : 백만원 ) 1분기 2분기 3분기 4분기 TOTAL 1분기 2분기 3분기 TOTAL 매출액 9,511 11,248 11,114 15,189 47,062 11,155 13,395 12,872 37,422 매출원가 4,433 46.6% 5,283 47.0% 5,355 48.2% 6,965 45.9% 22,036 46.8% 4,978 44.6% 6,296 47.0% 6,010 46.7% 17,283 46.2% 매출총이익 5,078 53.4% 5,965 53.0% 5,759 51.8% 8,224 54.1% 25,026 53.2% 6,177 55.4% 7,100 53.0% 6,862 53.3% 20,139 53.8% 판관비 2,533 26.6% 3,690 32.8% 3,093 27.8% 3,303 21.7% 12,619 26.8% 3,700 33.2% 4,240 31.7% 4,205 32.7% 12,146 32.5% 영업이익 2,545 26.8% 2,275 20.2% 2,666 24.0% 4,922 32.4% 12,408 26.4% 2,477 22.2% 2,859 21.3% 2,657 20.6% 7,993 21.4% 금융수익 241 2.5% 700 6.2% 606 5.5% 11 0.1% 1,558 3.3% 551 4.9% 1,763 13.2% 285 2.2% 2,598 6.9% 금융비용 2,738 28.8% -903-8.0% -316-2.8% 2,566 16.9% 4,084 8.7% 349 3.1% -30-0.2% 216 1.7% 535 1.4% 기타이익 50 0.5% 193 1.7% 277 2.5% 35 0.2% 554 1.2% 118 1.1% 1,028 7.7% 60 0.5% 1,206 3.2% 기타비용 389 4.1% 21 0.2% 236 2.1% 651 4.3% 1,297 2.8% 184 1.7% 83 0.6% 38 0.3% 305 0.8% 세전이익 -292-3.1% 4,050 36.0% 3,630 32.7% 1,751 11.5% 9,139 19.4% 2,613 23.4% 5,597 41.8% 2,748 21.3% 10,958 29.3% 법인세 -684-7.2% 595 5.3% 209 1.9% -171-1.1% -50-0.1% 960 8.6% -133-1.0% 153 1.2% 979 2.6% 당기순이익 392 4.1% 3,455 30.7% 3,421 30.8% 1,821 12.0% 9,089 19.3% 1,653 14.8% 5,730 42.8% 2,595 20.2% 9,978 26.7% EPS( 원 ) 55 488 483 258 1,284 233 809 367 1,410 33
손익계산서 ( 개별 ) Investment Highlights 2017년 2018년 ( 단위 : 백만원 ) 1분기 2분기 3분기 4분기 TOTAL 1분기 2분기 3분기 TOTAL 매출액 9,393 11,244 11,063 15,069 46,769 11,039 13,303 12,637 36,979 매출원가 4,422 47.1% 5,256 46.7% 5,414 48.9% 6,893 45.7% 21,985 47.0% 5,032 45.6% 6,243 46.9% 5,930 46.9% 17,206 46.5% 매출총이익 4,971 52.9% 5,988 53.3% 5,648 51.1% 8,176 54.3% 24,783 53.0% 6,007 54.4% 7,059 53.1% 6,707 53.1% 19,773 53.5% 판관비 2,464 26.2% 3,651 32.5% 3,014 27.2% 3,153 20.9% 12,282 26.3% 3,568 32.3% 4,157 31.3% 4,206 33.3% 11,931 32.3% 영업이익 2,507 26.7% 2,337 20.8% 2,634 23.8% 5,023 33.3% 12,502 26.7% 2,439 22.1% 2,902 21.8% 2,501 19.8% 7,842 21.2% 금융수익 238 2.5% 698 6.2% 602 5.4% 2 0.0% 1,541 3.3% 555 5.0% 1,759 13.2% 285 2.3% 2,598 7.0% 금융비용 2,738 29.1% -903-8.0% -316-2.9% 2,566 17.0% 4,084 8.7% 349 3.2% -30-0.2% 216 1.7% 535 1.4% 기타이익 50 0.5% 193 1.7% 277 2.5% 35 0.2% 554 1.2% 118 1.1% 996 7.5% 59 0.5% 1,174 3.2% 기타비용 389 4.1% 21 0.2% 236 2.1% 651 4.3% 1,297 2.8% 184 1.7% 82 0.6% 27 0.2% 293 0.8% 세전이익 -331-3.5% 4,111 36.6% 3,594 32.5% 1,843 12.2% 9,216 19.7% 2,579 23.4% 5,606 42.1% 2,601 20.6% 10,786 29.2% 법인세 -684-7.3% 595 5.3% 209 1.9% -70-0.5% 50 0.1% 960 8.7% -133-1.0% 153 1.2% 979 2.6% 당기순이익 353 3.8% 3,516 31.3% 3,384 30.6% 1,913 12.7% 9,166 19.6% 1,619 14.7% 5,739 43.1% 2,449 19.4% 9,807 26.5% EPS( 원 ) 50 497 478 270 1,295 229 811 367 1,406 0 34
Thank you For further question, please contract to IR team EY Kim head of IR /82-31-710-2411 / eykim@suprema.co.kr